Stay updated on Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial page
- CheckyesterdayChange DetectedPage revision updated from v3.6.4 to v3.6.5, indicating a newer build of the page. The study details and content remain unchanged.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, signaling a minor update to the page metadata. This change does not modify the study information or outcomes.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.3. This indicates a backend update to the page template and does not change study information or how the page functions for users.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page adds new helper labels and sections (Last verified, Last known status was, How to Read a Study Record, Common Questions, How to Join a Study) and updates the intervention label from 'Intervention / Treatment' to 'Intervention/Treatment' with a revision bump to v3.6.0.SummaryDifference1%

- Check66 days agoChange DetectedRevision: v3.5.5 replaces the previous v3.5.4 on the page. This indicates a minor platform/template update rather than any changes to study data or content.SummaryDifference0.1%

- Check88 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating a small metadata update rather than substantive content changes.SummaryDifference0.1%

Stay in the know with updates to Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combining GEN0101 and Pembrolizumab in Melanoma Clinical Trial page.